Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumor Metastatic Cancer Advanced Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05864144
What this trial is testing

SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more
Sensei Biotherapeutics, Inc. 98
Early research (Phase 1)Ended earlyNCT02122146
What this trial is testing

PF-06664178 In Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Pfizer 31
Early research (Phase 1)Study completedNCT00514007
What this trial is testing

Study of Continuous OSI-906 Dosing

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 95
Testing effectiveness (Phase 2)UnknownNCT03864575
What this trial is testing

An Open Label Phase II Study Combining Nivolumab and Celecoxib in Patients With Advanced " Cold " Solid Tumors

Who this might be right for
Metastatic Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 68
Early research (Phase 1)Study completedNCT00866528
What this trial is testing

Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05593094
What this trial is testing

Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsHER2-positive Breast Cancer
Hoffmann-La Roche 210
Testing effectiveness (Phase 2)UnknownNCT04913337
What this trial is testing

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
MesotheliomaGlioblastomaRenal Cell Carcinoma+12 more
NGM Biopharmaceuticals, Inc 179
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299
What this trial is testing

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT01661972
What this trial is testing

Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
John Strickler, M.D. 63
Testing effectiveness (Phase 2)Study completedNCT01611857
What this trial is testing

Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach

Who this might be right for
Malignant Solid TumourGastroesophageal Cancer
SCRI Development Innovations, LLC 49
Early research (Phase 1)Ended earlyNCT05480865
What this trial is testing

SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation

Who this might be right for
Solid Tumor, AdultMetastatic Solid TumorMetastatic NSCLC+1 more
Navire Pharma Inc., a BridgeBio company 28
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Early research (Phase 1)Study completedNCT00006036
What this trial is testing

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerLung CancerOvarian Cancer+1 more
NCIC Clinical Trials Group 14
Testing effectiveness (Phase 2)Looking for participantsNCT07262619
What this trial is testing

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Who this might be right for
Advanced Solid TumorsMSI-H or dMMR Advanced Solid TumorsMSI-H/dMMR Gastric Cancer+4 more
Eikon Therapeutics 160
Early research (Phase 1)Study completedNCT00004930
What this trial is testing

Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases

Who this might be right for
Lung CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00706030
What this trial is testing

Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer

Who this might be right for
Breast CancerAdvanced Malignant Solid Tumors
Puma Biotechnology, Inc. 92
Early research (Phase 1)Study completedNCT00778128
What this trial is testing

A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour

Who this might be right for
Solid Tumors
Clavis Pharma 26
Testing effectiveness (Phase 2)Looking for participantsNCT07193511
What this trial is testing

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Who this might be right for
Solid Tumor CancerLocally AdvancedMetastatic Solid Tumors+1 more
Avenzo Therapeutics, Inc. 355
Testing effectiveness (Phase 2)Active Not RecruitingNCT03673787
What this trial is testing

A Trial of Ipatasertib in Combination With Atezolizumab

Who this might be right for
Solid TumorGlioblastoma MultiformeProstate Cancer Metastatic
Institute of Cancer Research, United Kingdom 87
Early research (Phase 1)Study completedNCT00084643
What this trial is testing

GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IIIC Colon Cancer+6 more
National Cancer Institute (NCI) 20
Next Page